2010
DOI: 10.1177/147323001003800215
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Sperminated Pullulans on Drug Permeation through Isolated Rabbit Cornea and Determination of Ocular Irritation

Abstract: The aim of this study was to investigate the effect of two sperminated pullulans (SP) with a different number of amino groups (SP-L, amino group content 0.124 mmol/g polymer; and SP-H, amino group content 0.578 mmol/g polymer) on the permeation of drugs through isolated rabbit corneas. Determination of corneal hydration levels and Draize eye tests were performed to assess the safety of SP both in vitro and in vivo. For 0.2% (w/v) SP-L and 0.2% (w/v) SP-H, the enhancement ratios (ERs) with dexamethasone of 1.34… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
(27 reference statements)
0
1
0
Order By: Relevance
“…Due to its biocompatibility, multi-valency, solubility and biodegradability, pullulan has been widely used to produce nanoparticles or polymeric conjugates for systemic drug administration (Shingel, 2004;Singh et al, 2017). In ocular drug delivery, pullulan has been used only as mucoadhesive excipient for topical application (Pevet et al, 2011;Shingel, 2004;Singh et al, 2017), while its application for controlled or targeted intravitreal delivery is unexplored (Garhwal et al, 2012;Yu et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Due to its biocompatibility, multi-valency, solubility and biodegradability, pullulan has been widely used to produce nanoparticles or polymeric conjugates for systemic drug administration (Shingel, 2004;Singh et al, 2017). In ocular drug delivery, pullulan has been used only as mucoadhesive excipient for topical application (Pevet et al, 2011;Shingel, 2004;Singh et al, 2017), while its application for controlled or targeted intravitreal delivery is unexplored (Garhwal et al, 2012;Yu et al, 2010).…”
Section: Introductionmentioning
confidence: 99%